Search for dissertations about: "High density cholesterol"
Showing result 1 - 5 of 94 swedish dissertations containing the words High density cholesterol.
-
1. Effects of growth hormone on cardiovascular risk factors and atherosclerosis
Abstract : Hypopituitary patients with growth hormone (GH) deficiency (GHD) have increasedmorbidity and mortality from cardiovascular disease (CVD). GH treatment has both beneficialand potentially negative cardiovascular effects. READ MORE
-
2. Apolipoprotein A-I in glucose metabolism and amyloidosis
Abstract : The role of Apolipoprotein A-I (ApoA-I), the main protein component of HDL, in cholesterol transport and metabolism is well known and has been studied for more than four decades. More recently, ApoA-I protein has been shown to also have a positive role in glucose control by both stimulation of glucose uptake by muscles and by increasing glucose-stimulated pancreatic insulin secretion. READ MORE
-
3. Lipoproteomics : Environmental and Genetic Factors Affecting High-Density Lipoprotein (HDL)
Abstract : Lipoprotein particles act as lipid transporters in the blood stream, and measuring cholesterol content in specific subclasses of lipoprotein particles has long been, and still is, a frequently used tool to estimate the risk of cardiovascular disease (CVD). High-density lipoprotein (HDL) is a subclass of lipoproteins often regarded as providing protection against CVD via several functions including reverse cholesterol transport and anti-inflammatory capacities. READ MORE
-
4. Model Membranes and Their Interactions with Native and Artificial Lipoproteins
Abstract : Atherosclerosis arises from build-up of plaque in the blood, can result in cardiovascular disease and is the largest killer in the west. Low- and high-density lipoproteins are involved in the disease development by depositing and removing lipids to and from artery walls. READ MORE
-
5. Analysis of risk factors in patients with severe chronic kidney disease. The role of atorvastatin
Abstract : Background and aim: There had been no randomized end-point studies with statins for patients with severe renal failure. The purpose of this prospective, open, randomized, controlled study was to investigate whether atorvastatin (10 mg/day) would alter cardiovascular end-points and the overall mortality rate of patients with chronic kidney disease stage 4 or 5 (creatinine clearanceMaterial & Methods: This was an open, prospective, randomized study. READ MORE